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T
he absence of a decrease in diastolic blood pressure (dBP) during sleep is associated with a higher degree of target organ damage in normotensive and hypertensive nondiabetic subjects (1) . Among diabetic patients, this phenomenon has been described to occur more often in individuals with autonomic neuropathy (2) and with different degrees of diabetic nephropathy (3) (4) (5) . The reasons why this abnormal pattern of blood pressure is present more frequently in these groups of diabetic patients have not been completely elucidated. An increased extracellular volume (ECV) and nocturnal sympathetic predominance have been proposed as the mechanisms related to such blood pressure abnormalities in patients with diabetic nephropathy and autonomic dysfunction (2, 3, 6) .
We previously reported that, in normoalbuminuric normotensive type 1 diabetic patients without any degree of autonomic dysfunction, according to traditional cardiovascular tests, dBP night/day ratio was associated with an increased glomerular filtration rate (GFR) and an increased ECV (7) . Analysis of the factors related to the blunted decline in blood pressure in diabetic patients without advanced chronic complications could elucidate the pathophysiology of this abnormality.
Heart rate variability (HRV) refers to the variations of both instantaneous heart rate and R-R intervals and is usually evaluated by time domain methods and frequency domain methods such as power spectral analysis (PSA) (8) . Time domain indexes evaluate the dispersion of the R-R interval around the mean. These indexes are the results of the use of statistical methods on Autonomic function and blood pressure the measurements of the intervals between successive normal complexes and reflect overall autonomic modulation on the sinus node. PSA evaluates the variance of R-R intervals as a function of frequency and is calculated by mathematical algorithms. The result exhibits 3 main components: very low frequency, low frequency (LF), and high frequency (HF). The significance of the very low frequency component is dubious because its participation in HRV is less well defined. The LF component reflects mainly sympathetic modulation, especially when maneuvers that activate the sympathetic nervous system (e.g., passive tilt) are used (9) . The HF component is closely related to respiratory frequency reflecting vagal modulation to the sinus node. The ratio of power in LF/HF bands (LF/HF ratio) can be used as a measure of sympathovagal balance. At rest and during sleep, a predominance of vagal tone and an attenuation in sympathetic outflow is evident in normal individuals (10) . This behavior in autonomic modulation has been related to the nocturnal decline in blood pressure (11) . Spectral analysis of HRV has been considered to be a useful tool for the assessment of autonomic nervous system function in diabetic patients (12) .
The aim of this study was to analyze the role of autonomic function and other possible factors on nocturnal dBP decline in normotensive normoalbuminuric type 1 diabetic patients. For that purpose, HRV was evaluated using 24-h time domain analysis and PSA methods.
RESEARCH DESIGN AND METHODS

Patients
A total of 39 type 1 diabetic patients were selected from a cohort of 71 patients who have been followed at the outpatient clinic of the Hospital de Clínicas de Porto Alegre since 1986 (13) . The definition of type 1 diabetes was based on World Health Organization criteria (14) (i.e., Ͻ40 years of age at onset of diabetes, a previous episode of ketoacidosis or documented ketonuria, and obligatory use of insulin for life maintenance). Patients were included according to the following criteria: diabetes duration Ͼ1 year, Ͼ18 years of age, ambulatory blood pressure Ͻ140/90 mmHg, normoalbuminuria (24-h urinary albumin excretion rate [UAER] Յ20 µg/min) when measured on at least 2 occasions 3 months apart with sterile urine, normal maximal exercise electrocardiogram (ECG), and the absence of renal diseases and autonomic neuropathy (more than 1 abnormal result out of 5 cardiovascular autonomic reflex tests) (15) . The proportion of patients with 1 abnormal cardiovascular test was not different (P = 0.21) for dipper (29%) and nondipper patients (20%). None of the patients received any drug other than insulin. This study was approved by the ethics committee of the hospital, and informed consent was obtained from all patients.
Autonomic and blood pressure evaluation The ECG and the blood pressure recorders were installed simultaneously by the same investigator. The patients received verbal and written instructions to avoid ingesting alcoholic and caffeinated beverages, caffeinated medications, and systemic decongestants; to avoid vigorous exercise; and to avoid wearing elastic stockings 1 day before and on the day of the test. Patients were advised to maintain their usual daily activities and were asked to perform home blood glucose monitoring (before breakfast, lunch, and dinner and at 10:00 P.M. or if hypoglycemia was suspected) and to answer a questionnaire regarding the number of cigarettes smoked and other exceptional activity (extraphysical activity or arguing) on the day of the examination.
For HRV analysis, a 24-h ECG was recorded on cassette tapes using a CardioCorder Model 459 (Del Mar Avionics, Irvine, CA) and was analyzed by a cardiologist blinded to the patient' s status. Holter recordings were analyzed using a Del Mar Avionics scanner with a Version 750A Innovator with a semiautomatic technique. This program distinguishes normal beats from ectopies and artifacts and builds a time series of normal R-R intervals. Nonsinus beats were eliminated, and for PSA, missing data were interpolated. PSA was computed for periods of 256 s using fast Fourier transformation (16) . Only segments free of interpolations were analyzed. Power spectra were quantified by the area in 2 frequency bandwidths: 0.05-0.15 Hz (LF) and 0.15-0.5 Hz (HF). The total power and LF/HF ratio were calculated for each patient. The results were reported in normalized units (n.u.), except for the LF/HF ratio, which was calculated using absolute values (in milliseconds squared). Normalized units denote the relative value of each power component in proportion to the total power minus the very low frequency component.
Expressing the data in normalized units provides a quantitative index of sympathovagal interaction in the modulation of HRV. The following 24-h time domain indexes were also calculated: the mean of all R-R intervals (RRMED), the SD of the R-R intervals (SDNN), the mean of the SD of R-R intervals calculated in 5-min segments (SDNNi), the SD of the averages of the R-R intervals calculated in 5-min segments (SDANNi), the root mean square of successive differences of adjacent R-R intervals (RMSSD), and the percentage of differences between adjacent R-R intervals Ͼ50 ms (PNN50).
After coming to the laboratory in the morning, and after the ECG monitoring was started, all patients rested for 15 min in the supine position and underwent a tilt at 90°for 10 min. During the study, the room was kept quiet, and patients were instructed to breathe at their normal respiratory rate. The last 256-s segment of each period (at rest, 5 and 10 min after tilting) was used for PSA. The ECG was continuously recorded during the subsequent 24-h period. During the sleeping period, PSA was evaluated in the 256-s segment close to the lowest heart rate.
The protocol used for the 24-h ambulatory blood pressure measurement (Del Mar Avionics auscultatory technique) was previously described (7) . Patients who presented a dBP night/day ratio Ͼ0.9 were considered to be nondipper patients. A total of 15 type 1 diabetic patients were classified as nondipper patients, and 24 were classified as dipper patients. Sleep time was recorded as the period between the time when the patient went to bed and the time when the patient woke up in the morning.
Laboratory methods GFR was measured by the 51 Cr-EDTA single-injection technique (coefficient of variation [CV] = 12%), the estimated ECV was measured by the distribution volume of 51 Cr-EDTA, and the UAER was measured by radioimmunoassay (DPC, Los Angeles, CA) (inter-and intra-assay CVs were 2.3 and 2.8%, respectively). HbA 1 was measured by a microchromatographic system (Labtest, Lagoa Santa, Brazil) (normal range 5.3-8.0%).
Statistical analysis
Student' s t test and Fisher' s exact test were used to compare dipper and nondipper type 1 diabetic patients. The results of the tilt-table test were evaluated by analysis of variance for repeated measures. The relationship between the dBP night/day ratio and other variables was calculated by Pearson' s correlation coefficient. Forward stepwise multiple linear regression analysis was carried out to account for the relative contributions of different variables on the dBP night/day ratio. Variables with a P value Ͻ0.1 in the univariate analysis or with biological relevance for the dBP night/day ratio variation were entered in the model. HRV indexes and UAER were log transformed. Data are means ± SD except for the UAER (medians [ranges]). P values Ͻ0.05 (2-tailed) were considered to be statistically significant.
RESULTS
Clinical and laboratory characteristics
The clinical and laboratory characteristics of the type 1 diabetic patients are shown in Table 1 . The GFR was higher in nondipper patients than in dipper patients (P = 0.03). The ECV was also higher in nondipper patients but did not reach the conventional level of significance (P = 0.10). Nondipper and dipper patients did not differ regarding either the mean nocturnal dose of long-acting insulin (10.3 ± 4.1 and 11.5 ± 6.6 U, respectively, P = 0.69) or the number of patients receiving nocturnal insulin (58 and 60%, respectively, P = 0.50). By definition, dBP night/day ratio was higher in nondipper patients than in dipper patients (96 ± 6 and 84 ± 4%, respectively, P Ͻ 0.001). Systolic blood pressure (sBP) night/day ratio was also higher in nondipper than in dipper patients (90 ± 9 and 81 ± 9%, respectively, P = 0.004). Nondipper patients presented higher values of nocturnal sBP (106.0 ± 12.9 mmHg) and nocturnal dBP (73.4 ± 6.0 mmHg) than dipper patients (95.0 ± 12.4 and 65.5 ± 5.9 mmHg, P = 0.01 for both analyses). During the day, dipper and nondipper patients presented similar levels of mean sBP (118.0 ± 10.7 and 118.0 ± 12.7 mmHg, respectively) and mean dBP (77.8 ± 6.2 and 76.4 ± 6.3 mmHg, respectively).
Autonomic evaluation
Time domain HRV indexes (Table 2) were not different when both groups were compared (P Ͼ 0.05). PSA results are depicted in Table 3 . The LF component and the LF/HF ratio calculated during sleep were higher in the nondipper patients than in dipper patients (P = 0.008 and P = 0.007, respectively). The nocturnal LF component and the LF/HF ratio presented a significant positive correlation (r = 0.66, P = 0.008). HF component values during sleep were lower in nondipper patients, but the statistical significance was borderline (P = 0.08).
During the day, at rest in supine position immediately before the tilt-table test, the LF component of nondipper patients was higher than that of dipper patients (P = 0.04), but the LF/HF ratio and the HF component were similar. In the nondipper group, the LF component did not increase after the tilt-table test (P = 0.32), but in dipper patients, it increased significantly after the maneuver (P = 0.001). In both groups, the tilt-table test promoted a decrease (P = 0.003 for both groups) in the HF component (Table 3) .
Correlations and multiple regression analysis
The univariate analysis revealed a significant correlation between dBP night/day ratio and ECV (r = 0.36, P = 0.003) and a borderline significant correlation with GFR (r = 0.30, P = 0.056) and with log UAER (r = 0.29, P = 0.076). No correlation of the dBP night/day ratio was observed with the LF component during sleep (r = 0.18, P = 0.17) and with diabetes duration (r = 0.08, P = 0.62). A stepwise multiple linear regression analysis was performed with the dBP night/day ratio as the dependent variable and the ECV, LF component during sleep, and log UAER as independent variables. dBP night/day ratio was significantly (R 2 = 0.24, F = 5.79, P = 0.007) associated with log UAER (t = 2.084, P = 0.04) and the LF component (t = 2.766, P = 0.009) during sleep. ECV was excluded from the model (t = 0.106, P = 0.106).
DIABETES CARE, VOLUME 23, NUMBER 7, JULY 2000 991 CONCLUSIONS -The observed results indicate that this sample of nondipper normotensive normoalbuminuric type 1 diabetic patients presents an autonomic dysfunction characterized by sympathetic predominance, especially at night. In nondiabetic individuals, a decrease in sympathetic activity and an increase in vagal influence (LF/HF ratio decreases) occur during sleep, and this rhythm is associated with a decline in blood pressure (11) . The observed disruption of the circadian rhythm of sympathovagal activity in our nondipper patients was associated with higher levels in sBP and dBP and with a reduced decline in sBP and dBP levels during the night. To our knowledge, this association has never been described for normoalbuminuric type 1 patients without established autonomic neuropathy. The parasympathetic function was apparently less compromised in these patients. PNN50 and RMSSD, 2 time domain indexes that reflect parasympathetic activity, were not different when dipper and nondipper patients were compared. The PSA index of parasympathetic activity (the HF component) was also similar in both groups of patients. However, the nocturnal increase in the HF component (HF at sleep minus the diurnal HF before tilting) in nondipper patients (0.19 ± 0.12 n.u.) tended to be lower than in dipper patients (0.29 ± 0.16 n.u., P = 0.062). Moreover, because the nocturnal analysis was performed during the period with the lowest heart rate (i.e., a period of greater parasympathetic activity), minor degrees of parasympathetic dysfunction could not be detected in nondipper patients. These observations together with the expression of PSA results in normalized units (which represent the relative value of each power component [LF and HF] in relation to the total power) suggest that nondipper patients present an autonomic dysfunction during sleep characterized by an absence of the suppression of sympathetic drive and probably by a smaller increase in parasympathetic activity. This is supported by the observation of a higher nocturnal LF/HF ratio (which is an index of sympathovagal balance modulation on the sinus node) in nondipper patients.
Pecis and Associates
During the day, at rest in the supine position, the LF component was also higher in nondipper patients. However, the LF/HF ratio was similar in both groups of patients, which suggests that parasympathetic function during the day was not markedly compromised in nondipper patients. The similar diurnal sBP and dBP levels in dipper and nondipper patients reinforce this lesser degree of autonomic dysfunction during the day.
Parasympathetic activity was also normally suppressed in both dipper and nondipper patients after tilting. Typically, the tilt test induces a decrease in parasympathetic activity and an increase in sympathetic function (9) . The 90°tilt used in our study is a strong stimulus for this autonomic adaptation, which is evident from the almost complete suppression of vagal activity in our patients. A less intense stimulus (e.g., voluntary orthostatism) probably would not have been able to completely suppress the HF component in the nondipper group. In turn, nondipper patients did not present the expected increase in the LF component during the tilt test. The autonomic dysfunction observed in these patients probably makes their sympathetic system less responsive to physiological stimuli such as sleep and orthostatism. Therefore, the data suggest that the autonomic dysfunction of these normoalbuminuric nondipper type 1 diabetic patients is mainly related to a sympathetic predominance during the sleeping period.
Other authors using PSA also observed that the absence of nocturnal blood pressure decline was associated with an increased sympathetic predominance (2, 5) . This was recently confirmed by Nielsen et al. (6) , who reported increased levels of plasma noradrenaline during sleep in type 2 diabetic patients with a minor blood pressure decrease during the night. The increase in sympathetic activity observed by those authors was probably related to established autonomic neuropathy because the study included patients with a longer diabetes duration and abnormal cardiovascular tests. Spallone et al. (2) observed increased nocturnal sympathetic activity in 25 diabetic patients (type 1 and type 2) who did not present a reduction in nocturnal blood pressure. Patients with diabetic nephropathy (n = 8) and cardiovascular autonomic neuropathy (n = 6) were included. Sleep time in that study was defined as a fixed period from 10:00 P.M. to 8:00 A.M. and not as the actual interval between the moment when the patients went to bed and woke up in the morning. Poulsen et al. (5) reported that normoalbuminuric type 1 diabetic patients at risk for the development of microalbuminuria (UAER levels above the median) also presented abnormalities of sympathovagal balance associated with a blunted nocturnal blood pressure reduction. However, in contrast with our study, these authors observed a reduction in both the HF and LF components. This difference could be related to different maneuvers used to challenge the autonomic system (passive vs. active orthostatism), different criteria to categorize the patients (absence of nocturnal dBP decline vs. UAER above the median), longer diabetes duration (18 years), and probably the presence of a more advanced form of autonomic neuropathy.
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Autonomic function and blood pressure Data are means ± SD. Tilt effect was analyzed with repeated measures analysis of variance. LF/HF ratio was calculated using absolute values (in milliseconds squared).
